Skip to main content
All lobbying filings

THE MCMANUS GROUP

THE MCMANUS GROUP filed a Q2 report for DENDREON PHARMACEUTICALS LLC on July 21, 2025, reporting $30,000 in lobbying income.

Lobbying for DENDREON PHARMACEUTICALS LLC · Biopharmaceutical company.

All filings by THE MCMANUS GROUP · Everything DENDREON PHARMACEUTICALS LLC has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Lobbyists on this filing 1
  • JOHN MCMANUS
    Previously held: LA, Bill Thomas. Staff Director, W&M Health Subcommittee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.

Health Issues

Support for S. 297/H.R. 1300 - PSA Screening for HIM Act.

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem